Tirofiban:an investigational plateletglycoprotein IIb/IIIa receptor antagonist

Author： Kumar A.   Herrmann H.C.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.9, 1997-09, pp. : 1247-1256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Tirofiban, a Nonpeptide Glycoprotein IIb/IIIa Receptor Antagonist: Comparison with the Monoclonal Antibody Abciximab

By Kondo K.   Umemura K.  

Clinical Pharmacokinetics, Vol. 41, Iss. 3, 2002-01 ,pp. : 187-195

Adis International

Access to resources Recommend Favorite

Increased bleeding with GP IIb-IIIa antagonist use

By  

Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Platelet glycoprotein IIb/IIIa receptor antagonists

By Casserly I.P.   Moliterno D.J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 419-433

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist

By Moritani Y.   Sato K.   Shigenaga T.   Hisamichi N.   Ichihara M.   Akamatsu S.   Suzuki K.-i.   Nii T.   Kaku S.   Kawasaki T.   Matsumoto Y.   Inagaki O.   Tomioka K.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 439, Iss. 1, 2002-03 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists: Clinical Pharmacology in Cardiovascular Diseases of Aging

By Sebastian M.   Makkar R.  

Drugs & Aging, Vol. 15, Iss. 3, 1999-09 ,pp. : 207-218

Adis International

Access to resources Recommend Favorite